Skip to main content
Perspective:

Asia Pacific Private Equity 2026 Almanac with Southeast Asia Insights

2025: a year of recalibration for private equity in Southeast Asia

In a persistently uncertain global environment, investors did not retreat from the region, but they did become more selective. Deal activity moderated, yet capital continued to be deployed into transactions with clearer conviction, stronger downside protection, and more tangible value creation levers.

Southeast Asia recorded 56 buyout deals with total disclosed value of US$6.4B in 2025, compared with 74 deals worth US$9.4B in 2024. This moderation reflected a repricing of risk rather than a withdrawal of capital, as investors adapted to uncertainty.

 

Key Southeast Asia private equity insights

  • 56 buyout deals worth US$6.4B in 2025, down from 74 deals worth US$9.4B in 2024
  • Mid-market transactions accounted for 64% of buyout deal volume
  • TMT accounted for 41% of deal value and 30% of deal count
  • Healthcare accounted for 20% of deal count and 14% of deal value
  • Consumer accounted for 16% of total buyout deal count
  • Singapore accounted for approximately half of deal count and around 75% of deal value
  • Exit volume declined, while exit value held steady at US$4.5B
  • Trade sales and secondary buyouts accounted for approximately 74% of exits
  • Fundraising declined to US$3.3B, while dry powder remained elevated at US$21.1B
Within the region last year, secondary buyouts featured more prominently, as sponsors sought to recycle ownership, extend holding periods, and create time for additional value creation. In our view, there has always been a market for secondaries, and secondary funds will continue to grow. Overall, with the right returns, investors will be keen to invest in the right platforms.

 

Jamil Raza Syed, Deloitte Southeast Asia’s Private Equity Leader

Market themes

Mid-market buyouts formed the core of activity and accounted for 64% of buyout deal volume, supported by platform build-outs, bolt-on acquisitions, and an increased reliance on secondary buyouts as a practical route to liquidity.

Across the region, investment decisions reflected stronger emphasis on execution certainty, valuation discipline, and operational value creation rather than broad macro tailwinds.

The exit environment in Southeast Asia remained muted in 2025. Exit volume declined to 20, down from 28 in 2024, while total disclosed exit value held steady at US$4.5B.

Private equity sponsors continued to favour trade sales and secondary buyouts, which together accounted for approximately 74% of exits, reflecting a preference for execution certainty and pricing clarity in a constrained public-market environment.

At the same time, dry powder remained elevated at US$21.1B, despite fundraising declining to US$3.3B, reinforcing continued investor capacity to deploy capital as conditions improve.

Private equity activity concentrated around TMT, healthcare, and consumer, which together accounted for the majority of buyout deal volume and value.

Within TMT, investment shifted towards the digital infrastructure required to support AI-enabled and data-intensive workloads, including data centres and fibre platforms. Deloitte estimates Southeast Asia’s AI market could reach approximately US$65B by 2035.

In healthcare, activity centred on scaled provider platforms, pharmacy and outpatient access models, and healthcare services adjacencies, where operational uplift and consolidation remain achievable.

In consumer, investment remained selective and focused on service-led, repeat-use platforms, including education and consumer healthcare adjacencies.

Singapore remained the clear centre of private equity activity in Southeast Asia in 2025, accounting for approximately half of total buyout deal count and around 75% of buyout deal value.

Its role as the region’s primary hub for capital aggregation, deal structuring and ownership transitions continued to be reinforced by a higher concentration of larger and platform-level transactions.

Singapore also continues to serve as a preferred regional holding jurisdiction due to the relative certainty it offers in transaction taxes and the absence of withholding tax on outbound dividends. Together, these features provide investors with early visibility over exit outcomes and support structuring decisions upfront.

Across Southeast Asia more broadly, activity remained measured but resilient, reflecting sector-specific opportunities and selective consolidation plays.

Outlook for 2026

The Southeast Asia private equity market is set up for a more conducive phase, supported by conditions already visible in 2025.

Dry powder remains elevated, private equity firms continue to demonstrate strong intent to deploy capital, and a backlog of exits has accumulated following the slowdown in realisations in recent years.

If public markets remain selective, trade sales and sponsor-to-sponsor transactions are likely to continue anchoring exits, with secondaries playing a central role in extending value-creation runways.

On deployment, activity is expected to remain centred on mid-market buyouts and platform build strategies, particularly in digital infrastructure aligned to AI-enabled workloads, consolidation-led healthcare platforms, and defensible consumer services.

Overall, 2026 is likely to reward sponsors that translate 2025’s selectivity into execution.

Did you find this useful?

Thanks for your feedback